Compare TKNO & BRBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TKNO | BRBI |
|---|---|---|
| Founded | 1996 | 2009 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.1M | 293.2M |
| IPO Year | 2021 | 2025 |
| Metric | TKNO | BRBI |
|---|---|---|
| Price | $6.87 | $10.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 268.8K | 884.0 |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 5.03% |
| EPS Growth | ★ 43.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $40,520,000.00 | N/A |
| Revenue This Year | $8.27 | N/A |
| Revenue Next Year | $13.13 | $17.24 |
| P/E Ratio | ★ N/A | $11.72 |
| Revenue Growth | ★ 7.35 | N/A |
| 52 Week Low | $1.91 | $9.09 |
| 52 Week High | $7.84 | $67.01 |
| Indicator | TKNO | BRBI |
|---|---|---|
| Relative Strength Index (RSI) | 58.08 | 54.01 |
| Support Level | $4.87 | $10.90 |
| Resistance Level | $7.68 | $11.97 |
| Average True Range (ATR) | 0.45 | 0.10 |
| MACD | -0.07 | 0.23 |
| Stochastic Oscillator | 51.46 | 94.58 |
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
BRBI BR Partners SA, formerly BR Advisory Partners Participacoes SA, is engaged in investing in other companies, domestic or foreign, as a partner, quota holder, or shareholder, and management of its assets. It has a single reportable segment being investment banking services, which are administered and managed according to the products offered. However, the company divides it's operations into the following business lines: (1) investment banking and capital markets, (2) treasury sales & structuring, (3) investments and wealth management and (4) capital remuneration.